Spain marks one-year anniversary of deadly Valencia floods with state funeral
Spain held a state funeral on Wednesday to honor the 237 victims of the deadly Valencia floods that struck on October 29, 2024, the most catastrophic ...
Scientists in Australia and the U.S. have developed an AI tool that could transform cancer care by revealing the hidden diversity of tumour cells and guiding more targeted therapies.
A team of Australian and American researchers has unveiled a powerful new artificial intelligence (AI) tool designed to decode the complex biology of tumours and improve cancer treatment outcomes. The innovation addresses tumour heterogeneity—variations among cancer cells within the same tumour—that has long hindered the effectiveness of standard therapies.
Developed jointly by Sydney’s Garvan Institute of Medical Research and the Yale School of Medicine, the tool, known as AAnet, uses deep learning to analyse gene activity at the single-cell level. According to the researchers, AAnet can distinguish five distinct cell types within a tumour, each with unique behaviours and potential to spread, offering far more precision than traditional diagnostic methods.
“Heterogeneity is a problem because currently we treat tumours as if they are made up of the same cell,” said Associate Professor Christine Chaffer from the Garvan Institute, who co-led the study. “This means we give one therapy that kills most cells in the tumour by targeting a particular mechanism. But not all cancer cells may share that mechanism.”
By identifying the biological traits of different cancer cell populations, AAnet allows clinicians to tailor combination therapies that target all types of tumour cells at once, potentially reducing treatment resistance and relapse.
Co-developer Associate Professor Smita Krishnaswamy of Yale University described AAnet as the first tool capable of simplifying the complexity of tumour cells into actionable categories. She said it could pave the way for a new era of precision oncology where treatments are personalised to the unique cellular makeup of each patient’s tumour.
Validated initially in breast cancer, AAnet has also shown promise for other cancer types and even autoimmune diseases. The team plans to integrate AI insights with conventional diagnostics in clinical settings, offering personalised treatment plans based on the specific cell types within each tumour.
The findings were published in the journal Cancer Discovery, marking a significant step toward more effective, individualised cancer care.
A small, silent object from another star is cutting through the Solar System. It’s real, not a film, and one scientist thinks it might be sending a message.
At least 69 people have died and almost 150 injured following a powerful 6.9-magnitude earthquake off the coast of Cebu City in the central Visayas region of the Philippines, officials said, making it one of the country’s deadliest disasters this year.
A tsunami threat was issued in Chile after a magnitude 7.8 earthquake struck the Drake Passage on Friday. The epicenter was located 135 miles south of Puerto Williams on the north coast of Navarino Island.
The war in Ukraine has reached a strategic impasse, and it seems that the conflict will not be solved by military means. This creates a path toward one of two alternatives: either a “frozen” phase that can last indefinitely or a quest for a durable political regulation.
A shooting in Nice, southeastern France, left two people dead and five injured on Friday, authorities said.
Serious cases of a disorder of the large intestine are surging among Americans younger than 50, researchers say.
Russian President Vladimir Putin asked North Korean Foreign Minister Choe Son Hui during talks in the Kremlin on Monday to tell her country's leader Kim Jong Un that everything was "going to plan" in bilateral relations.
U.S. border czar says fentanyl should be considered a WMD.
U.S. states this week warned food aid recipients that their benefits may not be distributed in November if the federal government shutdown stretches into its fourth week.
The European Union is reportedly considering banning the use of ethanol as an active ingredient in biocidal products — including hand sanitisers — due to rising concerns about potential cancer risks, the Financial Times reported on Tuesday.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment